Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
65.02B | 58.06B | 45.82B | 40.15B | 43.88B | Gross Profit |
16.37B | 13.16B | 8.47B | 6.16B | 9.67B | EBIT |
11.40B | 8.76B | 4.40B | 2.08B | 5.44B | EBITDA |
34.95B | 33.35B | 24.26B | 17.11B | 17.07B | Net Income Common Stockholders |
5.19B | 6.44B | 3.28B | 1.25B | 1.72B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
38.31B | 27.57B | 23.66B | 21.12B | 19.59B | Total Assets |
276.46B | 274.95B | 237.57B | 205.10B | 175.79B | Total Debt |
167.38B | 181.19B | 173.73B | 153.29B | 120.75B | Net Debt |
129.69B | 153.62B | 150.07B | 132.18B | 101.16B | Total Liabilities |
195.04B | 206.51B | 190.19B | 166.36B | 134.48B | Stockholders Equity |
42.77B | 35.33B | 23.97B | 19.07B | 17.66B |
Cash Flow | Free Cash Flow | |||
18.13B | -2.02B | -17.87B | -36.80B | -7.00B | Operating Cash Flow |
27.95B | 26.38B | 19.90B | 13.14B | 14.48B | Investing Cash Flow |
8.49B | -18.42B | -31.48B | -40.57B | -18.37B | Financing Cash Flow |
-24.60B | -5.46B | 12.03B | 29.47B | 7.20B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | $328.31B | 14.16 | 6.80% | 2.72% | 2.11% | 6.44% | |
74 Outperform | €373.77B | 11.69 | 8.09% | 3.11% | 11.62% | 19.32% | |
71 Outperform | $2.12T | 4.49 | 16.96% | 6.28% | 9.34% | 111.80% | |
71 Outperform | ¥1.69T | 3.94 | 16.68% | 6.46% | 9.06% | 64.14% | |
71 Outperform | ¥20.90B | 6.15 | 0.81% | -3.45% | -17.51% | ||
67 Neutral | $1.21T | 4.16 | 18.65% | 4.42% | 13.21% | 165.36% | |
64 Neutral | $4.30B | 11.84 | 5.23% | 249.82% | 4.06% | -10.21% |